According to Drug Store News, Merck will see significant losses from the passage of the healthcare bill. They cite :
Medicaid rebates would cause it to incur costs of $35 million in first quarter 2010 and $170 million for the full year, while the elimination of a tax benefit for retiree prescription drug coverage would cause it to take a non-cash charge in the first quarter of $150 million.
Event through this, they project growth through the year 2012. Is your company facing the same thing when it comes to healthcare reform?
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
Subscribe
Blog Archive
-
▼
2010
(111)
-
▼
April
(8)
- American confidence in healthcare is falling
- State and Plan Leaders Convene at Medicaid Managed...
- Healthcare's impact on Pharma companies
- Colorado begins implementing healthcare reform
- State Plans Meet to Discuss Immediate Effects of H...
- Florida challenging healthcare reform
- 15th Annual Medicaid Drug Rebate Program brochure...
- Poll: Where would you like to see The Medicare Co...
-
▼
April
(8)
No comments:
Post a Comment